Read more about Intas Pharma files draft prospectus for IPO on Business Standard. Drug maker Intas Pharmaceuticals today said it has filed. Intas Pharmaceuticals, has filed its draft red herring prospectus (DRHP) with Securities and Exchange Board of India (SEBI) for an initial public. Intas Pharma DRHP News: Latest and Breaking News on Intas Pharma DRHP. Explore Intas Pharma DRHP profile at Times of India for photos, videos and latest .
|Published (Last):||28 December 2015|
|PDF File Size:||15.78 Mb|
|ePub File Size:||19.8 Mb|
|Price:||Free* [*Free Regsitration Required]|
New Delhi, May 26 RPG Rdhp Sciences has sold its Gujarat-based biotechnology unit to Intas Pharmaceuticals for Rs 25 crore to focus on core areas of business and improve long-term competitiveness in a rapidly changing market. Intas to buy Teva’s UK, Ireland assets for mn pounds. Subscribe to BioSpectrum India. Intas Pharma launches first etanercept biosimilar. Sun Pharma in early talks to buy Intas Vrhp. Mon, Dec 31, Updated Chandra kicks off divestment plan.
Intas Pharma files draft prospectus for IPO
Please click here to Sign-in or Sign-up. ChrysCap backs Curatio in latest pharma bet. Email Enter a valid email address.
From around the Web. Web Interface Conceived and Powered By: Its products are marketed in over 60 countries, either directly, through its subsidiaries or indirectly, through supply, distribution and other arrangements with various leading global pharmaceutical companies.
Desi pharma companies top in intsa globally.
Intas Pharmaceuticals files DRHP for IPO
Rahul Gandhi listed as ‘non-Hindu’. Enquiry Thanks for contacting us! The company is present in various major therapy areas such as those relating to neurology, psychiatry, cardiology, pain management, gastroenterology, diabetology, nephrology, urology, anti-infective therapy, dermatology, gynecology, respiratory system, oncology, critical care and ophthalmology with a strong focus on chronic therapy areas relating to neurology, psychiatry, drgp and diabetology.
All rights reserved Disclaimer. Sources said the group has started a process to sell drug discovery services company Advinus Therapeutics, drawing interest from private equity funds Kedaara Capital and True North as well as from strategic nitas, GVK Biosciences and Lambda, a unit of Intas Pharma. Visit Our Digital Magazine: Intas Pharma files for an IPO. Intas Pharma buys Spanish xrhp hospital business. Drugs sold sans regulator’s nod, safety studies.
Intas Pharma files for an IPO
It has also extended its presence into other therapy areas such as gynecology, infertility, arthritis and the respiratory. Nimish Hasmukhbhai Chudgar, Dr. It is currently ranked as the 12th largest pharmaceutical company in the country with a 2. The promoters of the company are Mr. Intas Pharma merges group companies, subsidiaries.
Monday, 31 December According to sources, the company has begun the groundwork inras the IPO and approached merchant bankers a couple of months ago. At present, domestic companies are marketing their products only in emerging markets, but the largest and most lucrative market for all pharmaceuticals — the US — is the next stop. We will get in touch with you shortly.
Drug-maker Intas Pharmaceuticals has merged all its group companies and subsidiaries over concerns about low profits. The IPO will be made through intzs public issue of equity shares of face value of Rs.
Binish Hasmukh Chudgar, Mr. The Ahmedabad-based company is considering licensing agreements with hospital-based businesses in these markets. Medical Council of India MCI will investigate a complaint against 11 doctors from Madhya Pradesh who are charged with accepting foreign jaunts sponsored by pharmaceutical company. Hyderabad-based pharma giant Aurobindo snaps up Portuguese co for Rs crore.
Please fill the all fields. Please note that comments are moderated and are generally published if they are on-topic and not abusive.
Intas Pharma eyes hospitals in Europe, US.
In what could further strengthen its business in European and non-European countries, Frhp based Intas Pharmaceuticals Ltd has acquired hospital business of Combino Pharm in Spain and Portugal for an undisclosed sum. MCI to probe foreign jaunts by MP doctors. Intas Pharma is a vertically integrated Indian pharmaceutical company with global operations, engaged in the development, manufacture and marketing of pharmaceutical formulation.